Medicolegal Implications of Mild Neurocognitive Disorder

Anca Bejenaru1, James M Ellison1,2,3

  • 1Department of Psychiatry and Behavioral Health, Christiana Care, Wilmington, DE, USA.

Abstract

Insights

Mild cognitive impairment (MCI) and mild neurocognitive disorder (MiND) have significant medicolegal consequences. Early recognition and discussion are crucial for managing risks and promoting advance planning for affected individuals.

Area of Science:

  • Neurology
  • Geriatrics
  • Legal Medicine

Background:

  • Mild cognitive impairment (MCI) or mild neurocognitive disorder (MiND) are often precursors to dementia.
  • These conditions involve significant cognitive changes but preserved independence.
  • Mild impairment carries substantial medicolegal implications for individuals and their support systems.

Purpose of the Study:

  • To review common causes of mild neurocognitive disorder (MiND).
  • To systematically review the medicolegal ramifications of mild cognitive impairment (MCI) or MiND.

Main Methods:

  • A systematic review of English-language literature was performed.
  • Searches included comprehensive terms and cited sources.

Main Results:

  • Cognitive domain impairments affect decision-making, informed consent, and financial management.
  • Abilities impacted include designating healthcare proxies, executing wills, and safe driving.

Conclusions:

  • Mild cognitive impairment (MCI) can lead to significant behavioral outcomes.
  • Clinicians should inform patients and caregivers about medicolegal concerns associated with cognitive decline.
  • Proactive identification and discussion aid in managing medicolegal risks and advance care planning.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
408
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
410
Role of Cerebellum and Prefrontal Cortex in Memory01:14

Role of Cerebellum and Prefrontal Cortex in Memory

The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
839
Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.2K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.3K